Home Cart Sign in  
Chemical Structure| 1429180-08-4 Chemical Structure| 1429180-08-4

Structure of Mutant IDH1 inhibitor
CAS No.: 1429180-08-4

Chemical Structure| 1429180-08-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Mutant IDH1 inhibitor is a potent mutant IDH1 R132H inhibitor with IC50 of < 72 nM.

Synonyms: Mutant IDH1 inhibitor

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Mutant IDH1 inhibitor

CAS No. :1429180-08-4
Formula : C25H34N6O3
M.W : 466.58
SMILES Code : CC(C)[C@@H](COC1=O)N1C2=NC(N[C@@H](C)C3=CC=C(CN4CCN(C(C)=O)CC4)C=C3)=NC=C2
Synonyms :
Mutant IDH1 inhibitor
MDL No. :MFCD28167739

Safety of Mutant IDH1 inhibitor

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
TF-1 cells 500 nM To assess the transforming ability of IDH1 R132H/D279N double mutant in TF-1 cells and its sensitivity to ivosidenib. Results showed that IDH1 R132H/D279N could induce cytokine-independent proliferation in TF-1 cells and was resistant to ivosidenib. NPJ Precis Oncol. 2022 Sep 2;6(1):61.
Human chondrosarcoma cells 82.5 μM 4 days To evaluate the effect of CP-91149 on cell apoptosis, results showed increased TUNEL-positive cells, indicating increased apoptosis. Cell Rep. 2023 Jun 27;42(6):112578.
Human chondrosarcoma cells 82.5 μM 18 h To evaluate the effect of CP-91149 on cell proliferation, results showed reduced BrdU incorporation, indicating inhibition of cell proliferation. Cell Rep. 2023 Jun 27;42(6):112578.
Human chondrosarcoma cells 82.5 μM 96 h To evaluate the effect of CP-91149 on cell viability, results showed significant reduction in cell viability. Cell Rep. 2023 Jun 27;42(6):112578.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Patient-derived xenograft model Intraperitoneal injection 50 mg/kg 5 days a week for 2 weeks To evaluate the effect of CP-91149 on tumor growth, results showed significant reduction in tumor size, tumor weight, and tumor volume, and reduced BrdU incorporation, indicating inhibition of cell proliferation. Cell Rep. 2023 Jun 27;42(6):112578.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.14mL

0.43mL

0.21mL

10.72mL

2.14mL

1.07mL

21.43mL

4.29mL

2.14mL

References

 

Historical Records

Categories